secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovis CORP (ENOV)
CIK:        0001420800
Form:       8-K
Filed at:   2022-03-14T23:59:59+00:00
Accession:  0001193125-22-074022
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Colfax schedules investor meetings for planned separation of ESAB, rename to Enovis
--------------------------------------------------------------------------------

- Virtual investor meetings held March 14, 2022 for Colfax and ESAB.
- Separation to create two independent public companies: Enovis (medical tech) and ESAB (fabrication tech).
- Post-separation, Colfax will be renamed Enovis Corporation and continue medical technology business.
- Investor presentations furnished as Exhibits 99.1 and 99.2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420800/000119312522074022/0001193125-22-074022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420800/000119312522074022/d312247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-074022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer